Plasma fibroblast growth factor 23 is associated with poor outcome and unsuccessful uptitration of guideline-recommended pharmacotherapy in patients with worsening heart failure

Back

HFA Premium Access

Plasma fibroblast growth factor 23 is associated with poor outcome and unsuccessful uptitration of guideline-recommended pharmacotherapy in patients with worsening heart failure

Session: Young Investigator Award: Clinical

Topic: Prognosis (using biomarkers)

Speaker: Assistant Professor J. Ter Maaten (Groningen, NL)

Event: HEART FAILURE 2016

Congress Presentation

Add to my library

About the speaker

Assistant Professor Jozine Ter Maaten

University Medical Centre Groningen, Groningen (Netherlands (The))

9 presentations

1 follower

5 more presentations in this session

Prognostic burden of heart failure diagnosed in primary care or secondary care: a population-based linked electronic health record cohort study in 2.1 million people

Speaker: Doctor S. Koudstaal (Gouda, NL)

Treatment with insulin increases mortality in diabetic patients with chronic heart failure: data from the GISSI-HF Trial.

Speaker: Doctor D. Cosmi (Perugia, IT)

Genetic screening in dilated and non-dilated cardiomyopathy: should we broaden our perspective?

Speaker: Mr M. Hazebroek (Maastricht, NL)

Access

Abstract

Renal venous pattern: a new parameter for predicting cardiorenal syndrome progression

Speaker: Doctor F. Monitillo (Pavia, IT)

The metabolic exercise cardiac and kidney indexes (mecki) score: a new prognostic tool in patients with heart failure. a multicenter comparison with seattle and hfss in a large cohort of patients

Speaker: Doctor M. Mapelli (Milan, IT)

Access the full session

Young Investigator Award: Clinical

Speakers: Assistant Professor J. Ter Maaten, Doctor S. Koudstaal, Doctor D. Cosmi, Mr M. Hazebroek, Doctor F. Monitillo...

Access

About the event

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources